Get started
Author

Michael Didriksen

CNVs conferring risk of autism or schizophrenia affect cognition in controls
2013 · Hreinn Stefansson, Andreas Meyer-Lindenberg, et al. · Nature · 713
Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia
2017 · P Steullet, J-H Cabungcal, et al. · Molecular Psychiatry · 364
PDF
Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychotics
2008 · Bernard Masri, Ali Salahpour, et al. · Proceedings of the National Academy of Sciences · 338
The Danish 22q11 research initiative
2015 · Henriette Schmock, Anders Vangkilde, et al. · BMC Psychiatry · 286
PDF
Disruption of Neurogenesis on Gestational Day 17 in the Rat Causes Behavioral Changes Relevant to Positive and Negative Schizophrenia Symptoms and Alters Amphetamine-Induced Dopamine Release in Nucleus Accumbens
2004 · Peter Flagstad, Arne Mørk, et al. · Neuropsychopharmacology · 216
Common variants at VRK2 and TCF4 conferring risk of schizophrenia
2011 · Stacy Steinberg, Simone de Jong, et al. · Human Molecular Genetics · 215
PDF
Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci
2013 · GROUP investigators, A D Børglum, et al. · Molecular Psychiatry · 185
PDF
Decrease in parvalbumin‐expressing neurons in the hippocampus and increased phencyclidine‐induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia
2005 · Silke Penschuck, Peter Flagstad, et al. · European Journal of Neuroscience · 130
PDF
Effects of the 5-HT7 receptor antagonist SB-258741 in animal models for schizophrenia
2002 · B Pouzet, M Didriksen, et al. · Pharmacology Biochemistry and Behavior · 120
Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe
2011 · M Rietschel, M Mattheisen, et al. · Molecular Psychiatry · 119
Translating genome-wide association findings into new therapeutics for psychiatry
2016 · Gerome Breen, Qingqin Li, et al. · Nature Neuroscience · 117
BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders
2015 · Christian R. Schubert, Patricio O’Donnell, et al. · Neuron · 112
PDF
Cognitive Deficits Caused by Late Gestational Disruption of Neurogenesis in Rats: a Preclinical Model of Schizophrenia
2004 · Peter Flagstad, Birte Y Glenthøj, et al. · Neuropsychopharmacology · 108
A Mouse Model that Recapitulates Cardinal Features of the 15q13.3 Microdeletion Syndrome Including Schizophrenia- and Epilepsy-Related Alterations
2013 · Kim Fejgin, Jacob Nielsen, et al. · Biological Psychiatry · 107
Common variant at 16p11.2 conferring risk of psychosis
2012 · S Steinberg, S de Jong, et al. · Molecular Psychiatry · 103
PDF
The heterozygous reeler mouse: behavioural phenotype
2003 · Jana Podhorna, Michael Didriksen · Behavioural Brain Research · 102
Genome-wide scans using archived neonatal dried blood spot samples
2009 · Mads V Hollegaard, Jonas Grauholm, et al. · BMC Genomics · 88
PDF
Reversal of PCP-induced learning and memory deficits in the Morris’ water maze by sertindole and other antipsychotics
2007 · Michael Didriksen, Torben Skarsfeldt, et al. · Psychopharmacology · 85
Analysis of the caudate nucleus transcriptome in individuals with schizophrenia highlights effects of antipsychotics and new risk genes
2022 · Kynon J. M. Benjamin, Qiang Chen, et al. · Nature Neuroscience · 82
PDF
Mutations inNRXN1in a family multiply affected with brain disorders:NRXN1mutations and brain disorders
2012 · Linh Duong, Laura L. Klitten, et al. · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 77
Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice
2016 · Michael Didriksen, Kim Fejgin, et al. · Journal of Psychiatry and Neuroscience · 75
PDF
Effects of antipsychotics on cognitive behaviour in rats using the delayed non-match to position paradigm
1995 · Michael Didriksen · European Journal of Pharmacology · 71
Investigating the neuroimmunogenic architecture of schizophrenia
2017 · R Birnbaum, A E Jaffe, et al. · Molecular Psychiatry · 68
Effects of the 5-HT6 receptor antagonist, SB-271046, in animal models for schizophrenia
2002 · B Pouzet, M Didriksen, et al. · Pharmacology Biochemistry and Behavior · 62
Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats
2011 · John P. Redrobe, Lisbeth Elster, et al. · Psychopharmacology · 60
Works count: 89
Citation count: 5,115
H-index: 36
I10-index: 58
Year
Topic
Type